These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6985198)

  • 1. [Experimental study on levamisole modulation of antitumor immunity--1].
    Saji S; Ooshita H; Adachi Y; Yamamoto S; Takekoshi T; Sakata K
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1418-26. PubMed ID: 6985198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological effect of splenectomy in tumor-bearing rat].
    Saji S; Sugiyama Y; Miya K; Oshita H; Yokoyama Y; Yamamoto S; Takekoshi T; Sakata K
    Nihon Geka Gakkai Zasshi; 1983 Mar; 84(3):179-85. PubMed ID: 6674791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study on immunological effect of splenectomy on tumor-bearers].
    Tanemura H; Saji S; Takekoshi T; Yamamoto S; Oshita H; Sakata K
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):982-6. PubMed ID: 6676670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependence of immunopotentiation and tumor regression induced by levamisole.
    Sampson D; Peters TG; Lewis JD; Metzig J; Kurtz BE
    Cancer Res; 1977 Oct; 37(10):3526-9. PubMed ID: 409485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopotentiation and tumor inhibition with levamisole.
    Sampson D
    Cancer Treat Rep; 1978 Nov; 62(11):1623-5. PubMed ID: 728892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of T- and B-lymphocytes in the spleen of mammary tumor-bearing rats to treatment with tamoxifen and soluble tumor-associated antigens.
    Ben-Hur H; Kossoy G; Sanko H; Geva D; Shumlin N; Zusman I; Elhayany A
    Oncol Rep; 2004 Jul; 12(1):181-5. PubMed ID: 15201981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of splenectomy on antitumor immune system in mice.
    Higashijima J; Shimada M; Chikakiyo M; Miyatani T; Yoshikawa K; Nishioka M; Iwata T; Kurita N
    Anticancer Res; 2009 Jan; 29(1):385-93. PubMed ID: 19331177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of the in vitro mitogenic response of owl monkey peripheral blood lymphocytes by levamisole and loss of this effect with the development of herpesvirus saimiri-induced lymphoma.
    Neubauer RH; Rabin H
    Clin Exp Immunol; 1978 Jul; 33(1):65-70. PubMed ID: 213219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor immunity in the relatively early period after cryosurgery. Experimental study using rat's metastasizing mammary tumor].
    Matsumura K; Misao A; Saji S; Kunieda T; Sakata K
    Nihon Geka Gakkai Zasshi; 1983 Nov; 84(11):1130-7. PubMed ID: 6674772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivating effect of levamisole on cell-mediated immunity in gastrointestinal cancer patients.
    Miwa H; Orita K
    Acta Med Okayama; 1977 Oct; 31(5):325-9. PubMed ID: 146404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of T and B lymphocytes in the spleen, lymph nodes and mammary tumors in rats treated with human soluble tumor-associated antigens and commercial human albumin.
    Ben-Hur H; Kossoy G; Mehrdad H; Elhayany A; Zusman I
    Oncol Rep; 2004 Dec; 12(6):1329-33. PubMed ID: 15547759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor immunity by murine cytokine activated T lymphocytes after cocultured with bone marrow derived dendritic cells pulsed with whole tumor lysates.
    Zhang S; Wang Q; Li WF; Wang HY; Zhang HJ
    Leuk Res; 2004 Oct; 28(10):1085-8. PubMed ID: 15289022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome.
    Czekalski S; Sulima D; Strzelecka G
    Proc Eur Dial Transplant Assoc; 1983; 19():800-3. PubMed ID: 6603617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of levamisole administration on treatment with 6-mercaptopurine riboside of mice bearing L1210 leukemia cells.
    Miura T; Nogiwa E; Kurashige S; Maekawa T
    Cancer Res; 1980 Dec; 40(12):4813-6. PubMed ID: 7438114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocompetent cells and lymphocyte reactivity to mitogens in levamisole-treated brain tumor children.
    Hajnzić TF; Kastelan M; Lukac J; Hajnzić T
    Pediatr Hematol Oncol; 1999; 16(4):335-40. PubMed ID: 10407870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of levamisole on lymphocytic reactivity in naso-laryngeal carcinoma].
    Stivala F; Malannino N; Cordopatri F; Campo M
    Boll Soc Ital Biol Sper; 1980 Aug; 56(16):1687-93. PubMed ID: 6970042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
    Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
    Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.